Scotland has high rates of death from diseases of the respiratory system and high rates of smoking, especially among women. Data on self reported smoking and prevalence of chronic cough and chronic phlegm among 10 359 men and women aged 40-59 years were obtained from the Scottish Heart Health Study. Overall, current cigarette smokers had rates of chronic cough and chronic phlegm four to five times those of never smokers after standardisation for age (32-3% v 6-5% for men and 24% v 5 5% for women for chronic cough; 31% v 8X3% for men and 21% v 5-5% for women for chronic phlegm). Ex-smokers' symptom rates were a little above those of never smokers and were significant for chronic cough among women and chronic phlegm among men. Men had higher symptom rates than women and this was true for smokers, ex-smokers, and never smokers. The higher rates among men could not be explained by higher cotinine concentrations. Tests to detect "deceivers" among ex-smokers and never smokers using biochemical validation suggested that 87 (1l5%) respondents were in fact smoking; they were excluded from analyses. There were substantially lower rates of chronic cough and chronic phlegm within a year of stopping smoking, and two to four years after stopping 89-99% of the difference between current smokers and never smokers was accounted for (99% and 93% for men and women with chronic cough, 96% and 89% for men and women with chronic phlegm). Even 10 years after stopping, rates of symptoms among ex-smokers remained a little above those of never smokers (except for women with chronic phlegm), though these differences were not statistically significant. Former heavy smokers continued to have rates of chronic cough and chronic phlegm that were higher than those of former light and moderate smokers (though not significantly so). These are cross sectional data, but they emphasise the importance for chronic bronchitis symptoms of giving up cigarette smoking, though the amount previously smoked continues to exert a small influence.
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Chronic bronchitis remains a major cause of morbidity and mortality in the developed world.' Scotland has one of the highest rates of death from diseases of the respiratory system in the world.2 Smoking is well known as a major risk factor for chronic bronchitis"5 and is now regarded as the main cause of chronic bronchitis and respiratory disease in the United Kingdom.6 Mortality from chronic bronchitis has been falling in the UK,' as have smoking rates.7
Two major symptoms of chronic bronchitis are chronic cough and chronic phlegm, and a decrease in chronic cough and chronic phlegm after quitting smoking has been reported.8
The rates of chronic cough and chronic phlegm among ex-smokers have been looked at in some large studies89 but these have not investigated the frequency of these symptoms over time since quitting for both men and women, or included objective validation of the claim to have given up smoking. One problem in the interpretation of the results of these studies is the possibility of deception among declared ex-smokers and never smokers, which could lead to higher rates of chronic bronchitis among apparent non-smokers. This paper uses data from a large cross sectional survey, the Scottish Heart Health Study,'0 and looks at chronic cough and chronic phlegm and their relation to smoking history, which has been verified with biochemical measurements.
Methods

POPULATION SAMPLE
The data used in this study of chronic bronchitis symptoms were taken from the Scottish Heart Health Study, which was set up to investigate the high incidence of coronary heart disease in Scotland. ' A strong dose-response relationship was found between the frequency of reported chronic phlegm and the level of cigarette smoking (as measured by cotinine quartile) among current cigarette smokers (fig 1) . Men had higher rates of respiratory symptoms than women at each level of smoking (p < 0 01 for quartiles I and II). The mean values for cotinine in each quartile were very similar for men and women and differed significantly only in the upper quartile, men having the higher mean (p < 0 001). Similar results were seen with carbon monoxide and thiocyanate quartiles.
The odds ratios for chronic cough and chronic phlegm in men and women for each cotinine quartile compared with the never smokers are shown in table 2. There is a clear dose-response effect with higher odds ratios in each successive cotinine quartile except for chronic cough among women, where the rate in the upper quartile of chronic cough is lower than that in the third quartile. This doseresponse effect was more pronounced for chronic cough than for chronic phlegm. The odds ratios are similar for men and women in each corresponding quartile for both chronic cough and chronic phlegm. Figure 2 shows the decrease in rates of reported chronic phlegm by the length of time since giving up smoking. For comparison, the rates The test for differences between proportions is between (1) <20/day v >20/day (*p < 0 05); (2) < 10 years since quitting v > 10 years since quitting (no differences significant).
EFFECTS OF GIVING UP SMOKING
also shows the rapidity with which these symptoms ofchronic bronchitis disappear after cessation of smoking and the much lower rates among ex-smokers than among current smokers. The frequency of chronic bronchitis symptoms for current cigarette smokers in this study are four to five times those of never smokers. This is similar to previous findings that rates for cigarette smokers were three to five times those of never smokers.921232426 The rates of chronic cough and chronic phlegm among ex-smokers are normally between those of never smokers and of current smokers; but in the case of men in the study by Higgins et aP3 and groups in the study of Friedman et al the rates are lower than those of the never smokers. In our study and most others5 21 24 25 the rates for ex-smokers are closer to those of the never smokers, but occasionally they are closer to those of the current smokers.27 A cohort study would have been able to verify whether the apparent effect of giving up smoking on the rates is genuine, or whether those who gave up had been different in their smoking habits from those who continued to smoke.
In conclusion, even one year after quitting smoking the rates of chronic cough and chronic phlegm are below those of most cigarette smokers. Even after 10 years, however, the rates are still above those of never smokers except for women with chronic phlegm, though these differences at this time are not significant. Those who had smoked heavily have higher rates even after some years than those who had been light or moderate smokers, though the trend is not significant. This study has confirmed that giving up smoking appears to reduce the frequency of chronic bronchitis symptoms very substantially and quickly.
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